A dairy bacterium displays in vitro probiotic properties for the pharyngeal mucosa by antagonizing group A streptococci and modulating the immune response
- PMID: 20732995
- PMCID: PMC2976356
- DOI: 10.1128/IAI.00559-10
A dairy bacterium displays in vitro probiotic properties for the pharyngeal mucosa by antagonizing group A streptococci and modulating the immune response
Abstract
The probiotic approach represents an alternative strategy in the prevention and treatment of infectious diseases, not only at the intestinal level but also at other sites of the body where the microbiota plays a role in the maintenance of physiological homeostasis. In this context, we evaluated in vitro the potential abilities of probiotic and dairy bacteria in controlling Streptococcus pyogenes infections at the pharyngeal level. Initially, we analyzed bacterial adhesion to FaDu hypopharyngeal carcinoma cells and the ability to antagonize S. pyogenes on FaDu cell layers and HaCat keratinocytes. Due to its promising adhesive and antagonistic features, we studied the dairy strain Lactobacillus helveticus MIMLh5, also through in vitro immunological experiments. First, we performed quantification of several cytokines and measurement of NF-κB activation in FaDu cells. MIMLh5 efficiently reduced the induction of interleukin-6 (IL-6), IL-8, and tumor necrosis factor alpha (TNF-α), in a dose-dependent manner. After stimulation of cells with IL-1β, active NF-κB was still markedly lowered. Nevertheless, we observed an increased secretion of IL-6, gamma interferon (IFN-γ), and granulocyte-macrophage colony-stimulating factor (GM-CSF) under these conditions. These effects were associated with the ability of MIMLh5 to enhance the expression of the heat shock protein coding gene hsp70. In addition, MIMLh5 increased the GM-CSF/G-CSF ratio. This is compatible with a switch of the immune response toward a TH1 pathway, as supported by our observation that MIMLh5, once in contact with bone marrow-derived dendritic cells, triggered the secretion of TNF-α and IL-2. In conclusion, we propose MIMLh5 as a potential probiotic bacterium for the human pharynx, with promising antagonistic and immunomodulatory properties.
Figures
Similar articles
-
In vitro functional and immunomodulatory properties of the Lactobacillus helveticus MIMLh5-Streptococcus salivarius ST3 association that are relevant to the development of a pharyngeal probiotic product.Appl Environ Microbiol. 2012 Jun;78(12):4209-16. doi: 10.1128/AEM.00325-12. Epub 2012 Apr 13. Appl Environ Microbiol. 2012. PMID: 22504812 Free PMC article.
-
Surface Layer of Lactobacillus helveticus MIMLh5 Promotes Endocytosis by Dendritic Cells.Appl Environ Microbiol. 2019 Apr 18;85(9):e00138-19. doi: 10.1128/AEM.00138-19. Print 2019 May 1. Appl Environ Microbiol. 2019. PMID: 30824443 Free PMC article.
-
Oral bacteria as potential probiotics for the pharyngeal mucosa.Appl Environ Microbiol. 2010 Jun;76(12):3948-58. doi: 10.1128/AEM.00109-10. Epub 2010 Apr 23. Appl Environ Microbiol. 2010. PMID: 20418429 Free PMC article.
-
Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health.Appl Microbiol Biotechnol. 2019 Aug;103(16):6463-6472. doi: 10.1007/s00253-019-09978-7. Epub 2019 Jul 2. Appl Microbiol Biotechnol. 2019. PMID: 31267231 Free PMC article. Review.
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
Cited by
-
Streptococcus pyogenes biofilms-formation, biology, and clinical relevance.Front Cell Infect Microbiol. 2015 Feb 11;5:15. doi: 10.3389/fcimb.2015.00015. eCollection 2015. Front Cell Infect Microbiol. 2015. PMID: 25717441 Free PMC article. Review.
-
Temporal Changes in Fecal Unabsorbed Carbohydrates Relative to Perturbations in Gut Microbiome of Neonatal Calves: Emerging of Diarrhea Induced by Extended-Spectrum β-lactamase-Producing Enteroaggregative Escherichia coli.Front Microbiol. 2022 Jul 7;13:883090. doi: 10.3389/fmicb.2022.883090. eCollection 2022. Front Microbiol. 2022. PMID: 35875583 Free PMC article.
-
Biotransformation strategy to reduce allergens in propolis.Appl Environ Microbiol. 2012 Jul;78(13):4654-8. doi: 10.1128/AEM.00811-12. Epub 2012 Apr 20. Appl Environ Microbiol. 2012. PMID: 22522681 Free PMC article.
-
Beneficial effects of probiotics in upper respiratory tract infections and their mechanical actions to antagonize pathogens.J Appl Microbiol. 2012 Dec;113(6):1305-18. doi: 10.1111/j.1365-2672.2012.05394.x. Epub 2012 Aug 3. J Appl Microbiol. 2012. PMID: 22788970 Free PMC article. Review.
-
Translating Recent Microbiome Insights in Otitis Media into Probiotic Strategies.Clin Microbiol Rev. 2019 Jul 3;32(4):e00010-18. doi: 10.1128/CMR.00010-18. Print 2019 Sep 18. Clin Microbiol Rev. 2019. PMID: 31270125 Free PMC article. Review.
References
-
- Ahola, A. J., H. Yli-Knuuttila, T. Suomalainen, T. Poussa, A. Ahlstrom, J. H. Meurman, and R. Korpela. 2002. Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors. Arch. Oral Biol. 47:799-804. - PubMed
-
- Arioli, S., C. Monnet, S. Guglielmetti, C. Parini, I. De Noni, J. Hogenboom, P. M. Halami, and D. Mora. 2007. Aspartate biosynthesis is essential for the growth of Streptococcus thermophilus in milk, and aspartate availability modulates the level of urease activity. Appl. Environ. Microbiol. 73:5789-5796. - PMC - PubMed
-
- Arpinati, M., C. L. Green, S. Heimfeld, J. E. Heuser, and C. Anasetti. 2000. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95:2484-2490. - PubMed
-
- Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286-290. - PubMed
-
- Bao, X. Q., and G. T. Liu. 2009. Induction of overexpression of the 27- and 70-kDa heat shock proteins by bicyclol attenuates concanavalin A-induced liver injury through suppression of nuclear factor-kappaB in mice. Mol. Pharmacol. 75:1180-1188. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources